Skip to main content
co.don AG logo

co.don AG — Investor Relations & Filings

Ticker · CNW ISIN · DE000A3E5C08 LEI · 3912006R73YW0SX1KG21 F Manufacturing
Filings indexed 88 across all filing types
Latest filing 2026-05-18 Report Publication Anno…
Country DE Germany
Listing F CNW

About co.don AG

https://www.codon.de/en/

co.don AG is a biopharmaceutical company specializing in tissue engineering and regenerative medicine. The company develops, manufactures, and markets autologous cell therapies for the minimally invasive, regenerative treatment of articular cartilage defects. Its core technology involves cultivating a patient's own cartilage cells (chondrocytes) and forming them into three-dimensional spheroids. This product, known as Spherox, is then implanted into the damaged knee cartilage to promote natural tissue regeneration. This personalized therapeutic approach aims to restore joint function and provide a durable, biological solution for cartilage repair.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2026
Report Publication Announcement Classification · 92% confidence The document is a preliminary announcement stating when the company will disclose its annual financial report for the 2023/2024 business year and provides a link for access. No actual financial data is included; it merely announces the publication date. This fits the definition of a Report Publication Announcement (RPA).
2026-05-18 English
Hinweis auf Jahresfinanzbericht vom 01.10.2023 bis zum 30.09.2024
Report Publication Announcement Classification · 92% confidence The document is a brief notice pointing shareholders to the annual financial report for the period 01.10.2023–30.09.2024, providing a link and publication date rather than containing any substantive financial data. This matches the definition of a Report Publication Announcement.
2026-05-18 German
Report Publication Announcement 2026
Report Publication Announcement Classification · 95% confidence The document is a short announcement (preliminary announcement) stating that the half-year/Q2 financial report for 2023/2024 will be disclosed on April 21, 2026, and provides a link to the report. It does not contain the report itself but informs investors about its upcoming publication. This matches the “Report Publication Announcement” category.
2026-04-17 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2023 bis zum 31.03.2024
Report Publication Announcement Classification · 87% confidence The document is a brief notice stating that the half-year financial report (01.10.2023 to 31.03.2024) “steht zur Verfügung” and providing a link, publication date, and distribution channels. It does not contain the actual financial report content. Under the “menu vs. meal” rule, this is an announcement of report availability rather than the report itself, so it is a Report Publication Announcement (RPA).
2026-04-17 German
Report Publication Announcement 2026
Report Publication Announcement Classification · 94% confidence The document is a short preliminary announcement stating that the company will publish its annual financial report on a specific date and provides a link for investors to view it. It does not contain the actual financial figures or report content but merely announces the forthcoming release. Under the “menu vs. meal” rule, this is a Report Publication Announcement.
2026-04-13 English
Halbjahresfinanzbericht nach WpHG für den Zeitraum vom 01.10.2022 bis zum 31.03.2023
Regulatory Filings
2026-03-10 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.